Stereotactic radiotherapy provides excellent local control for lung malignancies
March 20, 2012 By Gale Smith in Cancer
(Medical Xpress) -- Image-guided stereotactic radiation therapy is well tolerated and very effective in locally-controlling lung cancer, Methodist Cancer Center researchers report in the April issue of the Journal of Radiation Oncology.
Radiation oncologist Bin Teh, M.D., led the four-year study of 84 patients with primary, secondary or recurrent lung cancer. The use of stereotactic body radiation therapy (SBRT) over the course of five treatments in a two-week period resulted in 100 percent local control of all recurrent and metastatic lesions; and 92.6 percent local control of primary lung malignancies.
"These patients were not candidates for open surgery. By offering them SBRT, we were able to provide good, long-term local control and improve quality of life with minimal side effects from the treatment," said Teh, the paper's senior author and a pioneer of SBRT at Methodist. "Advances in radiotherapy, including SBRT, allow us to provide a more precise delivery that is non-invasive, and we can focus on the cancer site while preserving critical surrounding normal tissue."
SBRT is a technique that precisely targets radiation to a tumor while minimizing radiation to surrounding normal tissue such as the heart, esophagus, lung, spinal cord, bronchial trees and blood vessels. This targeting allows treatment of small- or moderate-sized tumors in either a single or limited number of fractions. Teh has treated more than 500 patients with SBRT, also known as stereotactic ablative body radiotherapy (SABR), for multiple tumor sites including lung, liver, spine, bone, lymph nodes, adrenal and kidney over the past eight years. Advances in image-guided radiotherapy (IGRT) also allow for more accurate treatment plans prior to radiotherapy.
Additional research to compare SBRT and open surgery is ongoing. Teh says current literature suggests SBRT is as good as open surgery, but patients tolerate SBRT better and there are no risks from anesthesia, bleeding, infection and recovery time.
Study patients received outpatient SBRT treatment five times over a two-week period, instead of the conventional daily radiation therapy over a six-to-eight-week timeframe. These patients received more potent treatments, delivering higher dosages of radiation each day, which resulted in better control of overall tumor growth.
Additional study co-authors from Methodist include Dr. Brian Butler, chairman of the department of radiation oncology; Drs. Arnold Paulino and Angel Blanco, radiation oncologists; Dr. Shanda Blackmon, thoracic surgeon; and Dr. Stephen Chiang, nuclear medicine radiologist.
Patients with pathologically proven malignant lung lesions were treated using SBRT with prescribed doses of 40, 50, and 60 Gy in five treatments. One hundred and three lesions were treated in 84 patients between June 2004 and June 2008, and 69 lesions in 56 patients were eligible in this analysis. No severe (grade >2) toxicities were noted. Two-year local control rates were 92.6 percent and 100 percent for primary and recurrent/metastatic groups, respectively.
Study patients were reviewed by the Methodist Cancer Center's multi-disciplinary thoracic tumor board, consisting of thoracic oncology surgeons; pathologists specializing in thoracic/lung cancer; diagnostic radiologists, including nuclear medicine physicians; radiation oncologists; and medical oncologists. Patients with smaller tumor and higher dosage showed improved survival. The study suggests that dosage is important in the SBRT approach, but additional research is needed.
The research was supported by in part by a Grant-in-Aid 361 for Cancer Research from Cancer Fighters of Houston, Inc.
Provided by Methodist Hospital System
-
ASTRO releases SBRT for lung cancer report
Apr 28, 2010 |
not rated yet |
0
-
SBRT provides better outcomes than surgery for cancer patients with common lung disease
Feb 16, 2012 |
not rated yet |
0
-
Precision radiation therapy may improve survival rates of some lung cancer patients
Mar 16, 2010 |
not rated yet |
0
-
Surviving lung cancer: New technique boasts high cure rates, offers hope in place of surgery
Mar 04, 2009 |
not rated yet |
0
-
Stereotactic radiotherapy stops lung cancer from growing in frail patients
Nov 02, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
23 hours ago
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
New smartphone application improves colonoscopy preparation
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer
1 hour ago |
not rated yet |
0
Research examines new methods for managing digestive health
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer
2 hours ago |
not rated yet |
0
New colonoscope provides ground-breaking view of colon
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer
17 hours ago |
5 / 5 (2) |
0
ASCO: combo antibody therapy effective for melanoma
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer
May 17, 2013 |
not rated yet |
0
Risk factors ID'd for poor cutaneous cell CA outcomes
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer
May 17, 2013 |
not rated yet |
0
|
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
New research identifies practice changes to improve value and quality of GI procedures
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
New research identifies risks, interventions for children's GI health
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
US psychiatry gets makeover in new manual
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
New case of SARS-like virus in Saudi: ministry
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.